Nursing care for patients with hemophilia pseudotumor in coagulation factor replacement therapy during perioperative period
10.3760/cma.j.issn.1674-2907.2018.07.023
- VernacularTitle:血友病假瘤患者围手术期凝血因子替代疗法的护理
- Author:
Jing LIU
1
;
Jiliang ZHAI
;
Yaping CHEN
Author Information
1. 100730,中国医学科学院北京协和医院骨科三病房
- Keywords:
Nursing care;
Hemophilia;
Pseudotumor;
Coagulation factors;
Replacement therapy
- From:
Chinese Journal of Modern Nursing
2018;24(7):836-838
- CountryChina
- Language:Chinese
-
Abstract:
Objective To summarize the nursing methods for patients with hemophilia pseudotumor in coagulation factor replacement therapy during perioperative period. Methods A retrospective analysis was conducted among 25 hemophilia pseudotumor patients who were in the Orthopedic Department of Peking Union Medical College Hospital from June 2010 to September 2016, which were selected by convenience sampling method. All the patients were assessed for psychological status in a standardized method throughout the whole process and given timely intervention. The precise management of preoperative coagulation factor pretest, venous protection, observation and nursing of postoperative wound bleeding, monitoring and nursing of coagulation factor inhibitors were standardized using "Coagulation Factor Replacement Treatment Pre-experiment Information Record Table". Results All patients received accurate coagulation factor replacement therapy in perioperative period, which ensured the safety of perioperative period. In addition, all patients were discharged smoothly with an average hospitalization duration of 40.5 days. Conclusions Coagulation factor replacement therapy is the foundation to ensure patient safety, the key of which is accurate nursing. This study provides clinical practice experience for related nursing in China, and lays the foundation for further in-depth research in the future.
